Literature DB >> 23564324

Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor.

Zhanwen He1, Danyang Cen, Xiangyang Luo, Dongfang Li, Pinggan Li, Liyang Liang, Zhe Meng.   

Abstract

Invasiveness is a major clinical feature of glioma, an aggressive brain tumor with poor prognosis. Although there is emerging evidence that some microRNAs are involved in the glioma cell invasion process, it remains necessary to find functional microRNAs and elucidate the underlying molecular mechanisms. Here, we reported that a microRNA, miR-383, was downregulated in gliomas and inversely correlated with glioma pathological grades. Downregulation of miR-383 enhanced, whereas upregulation of miR-383 inhibited, the glioma cell invasive ability. Furthermore, we found that downregulation of miR-383 activated the AKT signaling following upregulation of MMP2 expression by directly targeting insulin-like growth factor 1 receptor (IGF1R). Importantly, we demonstrated that IGF1R expression is critical for miR-383 downregulation-induced cell invasion. Taken together, these findings uncover a novel regulatory mechanism for constitutive IGF1R signaling activation in glioma cancer and may provide miR-383 as a useful diagnostic marker or therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23564324     DOI: 10.1007/s12032-013-0557-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  23 in total

1.  Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1.

Authors:  Mianmian Yin; Mingrong Lü; Guidong Yao; Hui Tian; Jie Lian; Lin Liu; Meng Liang; Yong Wang; Fei Sun
Journal:  Mol Endocrinol       Date:  2012-05-16

Review 2.  The role of the insulin-like growth factor system in human cancer.

Authors:  H Werner; D LeRoith
Journal:  Adv Cancer Res       Date:  1996       Impact factor: 6.242

3.  MicroRNA-21 is involved in osteosarcoma cell invasion and migration.

Authors:  Wu Ziyan; Yang Shuhua; Weng Xiufang; Liu Xiaoyun
Journal:  Med Oncol       Date:  2010-05-18       Impact factor: 3.064

Review 4.  Genetics of adult glioma.

Authors:  McKinsey L Goodenberger; Robert B Jenkins
Journal:  Cancer Genet       Date:  2012-12-11

5.  miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2.

Authors:  Wei Zhu; DanXia Zhu; Shiqiang Lu; Tongshan Wang; Jian Wang; Binghua Jiang; Yongqian Shu; Ping Liu
Journal:  Med Oncol       Date:  2011-01-22       Impact factor: 3.064

Review 6.  The insulin and insulin-like growth factor receptor family in neoplasia: an update.

Authors:  Michael Pollak
Journal:  Nat Rev Cancer       Date:  2012-02-16       Impact factor: 60.716

7.  Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1.

Authors:  J Lian; H Tian; L Liu; X-S Zhang; W-Q Li; Y-M Deng; G-D Yao; M-M Yin; F Sun
Journal:  Cell Death Dis       Date:  2010-11-04       Impact factor: 8.469

8.  MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3).

Authors:  Kay Ka-Wai Li; Jesse Chung-Sean Pang; Kin-Mang Lau; Liangfu Zhou; Ying Mao; Yin Wang; Wai-Sang Poon; Ho-Keung Ng
Journal:  Brain Pathol       Date:  2013-01-09       Impact factor: 6.508

9.  Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.

Authors:  Donglei Zhang; Menashe Bar-Eli; Sylvain Meloche; Pnina Brodt
Journal:  J Biol Chem       Date:  2004-03-01       Impact factor: 5.157

10.  Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.

Authors:  Junya Furukawa; Christopher J Wraight; Susan M Freier; Eigan Peralta; Lynne M Atley; Brett P Monia; Martin E Gleave; Michael E Cox
Journal:  Prostate       Date:  2010-02-01       Impact factor: 4.104

View more
  22 in total

1.  Liver-specific knockout of histone methyltransferase G9a impairs liver maturation and dysregulates inflammatory, cytoprotective, and drug-processing genes.

Authors:  Hong Lu; Xiaohong Lei; Qinghao Zhang
Journal:  Xenobiotica       Date:  2018-07-23       Impact factor: 1.908

2.  Effects of sorafenib on lung metastasis in rats with hepatocellular carcinoma: the role of microRNAs.

Authors:  Yi Shi; Aimin Huang
Journal:  Tumour Biol       Date:  2015-05-31

3.  Neuroprotective effect of miR-665 against sevoflurane anesthesia-induced cognitive dysfunction in rats through PI3K/Akt signaling pathway by targeting insulin-like growth factor 2.

Authors:  Xihua Lu; Shuaiguo Lv; Yan Mi; Lei Wang; Gensheng Wang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

4.  Deciphering specific miRNAs in brain tumors: a 5-miRNA signature in glioblastoma.

Authors:  João Basso; Marco G Paggi; Ana Fortuna; Carla Vitorino; Rui Vitorino
Journal:  Mol Genet Genomics       Date:  2022-02-17       Impact factor: 3.291

5.  miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.

Authors:  Lin Chen; Haitao Guan; Chunyan Gu; Yali Cao; Jianguo Shao; Feng Wang
Journal:  Tumour Biol       Date:  2015-09-18

6.  Activation of NMDA receptor of glutamate influences MMP-2 activity and proliferation of glioma cells.

Authors:  Palaniswamy Ramaswamy; N Aditi Devi; K Hurmath Fathima; Nandakumar Dalavaikodihalli Nanjaiah
Journal:  Neurol Sci       Date:  2013-12-29       Impact factor: 3.307

7.  Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.

Authors:  Ana Herman; Kristina Gruden; Andrej Blejec; Vid Podpečan; Helena Motaln; Primož Rožman; Matjaž Hren; Klemen Zupančič; Matija Veber; Urška Verbovšek; Tamara Lah Turnšek; Andrej Porčnik; Marjan Koršič; Miomir Knežević; Matjaž Jeras
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

8.  Mode of action and pharmacogenomic biomarkers for exceptional responders to didemnin B.

Authors:  Malia B Potts; Elizabeth A McMillan; Tracy I Rosales; Hyun Seok Kim; Yi-Hung Ou; Jason E Toombs; Rolf A Brekken; Mark D Minden; John B MacMillan; Michael A White
Journal:  Nat Chem Biol       Date:  2015-04-13       Impact factor: 15.040

9.  Understanding the aristolochic acid toxicities in rat kidneys with regulatory networks.

Authors:  Yin-Ying Wang; Zhiguang Li; Tao Chen; Xing-Ming Zhao
Journal:  IET Syst Biol       Date:  2015-08       Impact factor: 1.615

Review 10.  Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Mol Cancer       Date:  2014-02-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.